These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 8093979

  • 1. 5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder.
    Waldman FM, Carroll PR, Cohen MB, Kerschmann R, Chew K, Mayall BH.
    Mod Pathol; 1993 Jan; 6(1):20-4. PubMed ID: 8093979
    [Abstract] [Full Text] [Related]

  • 2. Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer.
    Waldman FM, Carroll PR, Kerschmann R, Cohen MB, Field FG, Mayall BH.
    Cancer Res; 1991 Jul 15; 51(14):3807-13. PubMed ID: 1676611
    [Abstract] [Full Text] [Related]

  • 3. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
    Pantazopoulos D, Ioakim-Liossi A, Karakitsos P, Aroni K, Kakoliris S, Kanavaros P, Kyrkou KA.
    Anticancer Res; 1997 Jul 15; 17(1B):781-6. PubMed ID: 9066620
    [Abstract] [Full Text] [Related]

  • 4. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings.
    Serio G.
    Pathologica; 1994 Apr 15; 86(2):161-6. PubMed ID: 7936759
    [Abstract] [Full Text] [Related]

  • 5. [Growth fractions of bladder cancer determined by proliferating cell nuclear antigen immunostaining].
    Kuroda H, Yasunaga Y, Takatera H, Fujioka H, Ohnishi A, Tsujimoto M.
    Hinyokika Kiyo; 1994 May 15; 40(5):379-82. PubMed ID: 7912881
    [Abstract] [Full Text] [Related]

  • 6. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
    Cheville JC, Terrell RB, Cohen MB.
    Mod Pathol; 1994 Sep 15; 7(7):794-800. PubMed ID: 7824516
    [Abstract] [Full Text] [Related]

  • 7. Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder.
    Cohen MB, Waldman FM, Carroll PR, Kerschmann R, Chew K, Mayall BH.
    Hum Pathol; 1993 Jul 15; 24(7):772-8. PubMed ID: 8100555
    [Abstract] [Full Text] [Related]

  • 8. [Expression of proliferating cell nuclear antigen in superficial bladder cancer--application to paraffin-embedded tissue sections].
    Wada T, Shimabukuro T, Kurisu H, Shameem IA, Yoshihiro S, Matsuyama H, Naito K, Hashimoto O, Tanaka K.
    Hinyokika Kiyo; 1993 Apr 15; 39(4):313-9. PubMed ID: 8099249
    [Abstract] [Full Text] [Related]

  • 9. The role of different biomarkers (DNA, PCNA, apoptosis and karyotype) in prognostic evaluation of superficial transitional cell bladder carcinoma.
    Lavezzi AM, Biondo B, Cazzullo A, Giordano F, Pallotti F, Turconi P, Matturri L.
    Anticancer Res; 2001 Apr 15; 21(2B):1279-84. PubMed ID: 11396199
    [Abstract] [Full Text] [Related]

  • 10. Cell proliferation of transitional cell bladder cancer determined by PCNA/cyclin immunostaining. A histopathological description.
    Lipponen PK, Eskelinen MJ.
    Anticancer Res; 1992 Apr 15; 12(2):577-83. PubMed ID: 1349799
    [Abstract] [Full Text] [Related]

  • 11. Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue.
    Wijsman JH, Van Dierendonck JH, Keijzer R, van de Velde CJ, Cornelisse CJ.
    J Pathol; 1992 Sep 15; 168(1):75-83. PubMed ID: 1360499
    [Abstract] [Full Text] [Related]

  • 12. Comparison of proliferating cell nuclear antigen versus the more standard measures of rectal mucosal proliferation rates in subjects with a history of colorectal cancer and normal age-matched controls.
    Einspahr J, Alberts D, Xie T, Ritchie J, Earnest D, Hixson L, Powell M, Roe D, Grogan T.
    Cancer Epidemiol Biomarkers Prev; 1995 Jun 15; 4(4):359-66. PubMed ID: 7655331
    [Abstract] [Full Text] [Related]

  • 13. PCNA immunostaining as a valid alternative to tritiated thymidine-autoradiography to detect proliferative cell fraction in transitional cell bladder carcinomas.
    Lavezzi AM, Terni L, Matturri L.
    In Vivo; 2000 Jun 15; 14(3):447-51. PubMed ID: 10904880
    [Abstract] [Full Text] [Related]

  • 14. [Prognostic study of cell proliferative markers ki67, PCNA and p53 oncoprotein in bladder tumors].
    Ben Rejeb A, Mahjoub A, Berraies N, Tissaoui K.
    Ann Urol (Paris); 2000 Aug 15; 34(4):240-8. PubMed ID: 10994143
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical analysis of p53 and proliferating cell nuclear antigen (PCNA) in bladder cancer: positive immunostaining and radiosensitivity.
    Ogura K, Habuchi T, Yamada H, Ogawa O, Yoshida O.
    Int J Urol; 1995 Nov 15; 2(5):302-8. PubMed ID: 8749948
    [Abstract] [Full Text] [Related]

  • 16. [Expression of PCNA/cyclin, p53, C-erbB-2 versus histological grade in transitional cell carcinoma of urinary bladder].
    Yoshikawa H, Ikeuchi T, Iguchi H, Onodera Y, Kai Y.
    Hinyokika Kiyo; 1995 Apr 15; 41(4):253-8. PubMed ID: 7785554
    [Abstract] [Full Text] [Related]

  • 17. Flow cytometric measurements of deoxyribonucleic acid ploidy and proliferative activity for evaluating malignant potential of human bladder cancers.
    Miyakawa A, Tachibana M, Tazaki H.
    Cancer Detect Prev; 1995 Apr 15; 19(2):165-72. PubMed ID: 7750104
    [Abstract] [Full Text] [Related]

  • 18. The effect of incubation of rectal biopsies on measures of proliferation using proliferating cell nuclear antigen in comparison with 5-bromo-2-deoxyuridine.
    Kilias D, Macrae FA, Sharpe K, Young GP.
    Cancer Epidemiol Biomarkers Prev; 1997 Oct 15; 6(10):819-24. PubMed ID: 9332765
    [Abstract] [Full Text] [Related]

  • 19. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
    Tachibana M, Miyakawa A, Nakamura K, Baba S, Murai M, Tazaki H.
    J Urol; 1996 Jul 15; 156(1):63-9. PubMed ID: 8648839
    [Abstract] [Full Text] [Related]

  • 20. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
    Kurokawa H, Yamashita Y, Takeda S, Miura K, Murata T, Kajiyama M.
    Fukuoka Igaku Zasshi; 1999 Jan 15; 90(1):6-13. PubMed ID: 10087668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.